Bovine Mastitis Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Report Covers Global Mastitis Market Growth and is Segmented by Type (Clinical and Sub-Clinical), Product (Antibiotics, Surgery, Vaccines, Pain Killers, and Other Products), Route of Administration (Intra-Mammary and Systemic), Therapy (Lactating Period and Dry Period), End Users (Hospitals, Veterinary Centers, and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The Value is Provided in (USD Million) for the Above Segments.

Bovine Mastitis Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Bovine Mastitis Market Size

Bovine Mastitis Market Summary
Study Period 2019 - 2030
Market Size (2025) USD 1.68 Billion
Market Size (2030) USD 2.13 Billion
CAGR (2025 - 2030) 4.88 %
Fastest Growing Market Asia-Pacific
Largest Market North America
Market Concentration Medium

Major Players

Bovine Mastitis Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Bovine Mastitis Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Bovine Mastitis Market Analysis

The Bovine Mastitis Market size is estimated at USD 1.68 billion in 2025, and is expected to reach USD 2.13 billion by 2030, at a CAGR of 4.88% during the forecast period (2025-2030).

The COVID-19 pandemic had an unprecedented impact on the growth of the bovine mastitis market. In 2020, it significantly impacted the supply chain of products for the treatment of bovine mastitis. Containment measures, such as lockdowns and social distancing, created problems in terms of the availability of medicines due to reduced operations in veterinary pharmacies. However, the relaxation of strict regulations post the pandemic led to the normal functioning of supply chain, which contributed to the market's growth.

The major factors responsible for the growth of the bovine mastitis market include the rising incidences of disease, the increasing product launches for animal healthcare, and technological advancements in the field of drug discovery and development.

Bovine mastitis is one of the major concerns in the dairy industry worldwide. Dairy farmers are facing huge economic losses with the rising incidences of cattle death globally. For instance, as per the data published by the MSD Manual in October 2022, severe mastitis caused by coliforms results in an higher incidence of cow death (30-50%) worldwide. These mortality rates in cows increase the direct and indirect costs, such as diagnostics, milk loss, veterinary services, labor, future milk production losses, and therapeutics. The rising bovine mastitis cases and related market loss are fuelling the demand for antibiotics in the treatment of the condition.

The increasing investments in the development of bovine mastitis treatment are expected to contribute to the market's growth. For instance, in August 2021, Stonehaven Incubates invested in the Anifera to conduct additional studies to explore the impact and effectiveness of adjunct therapy in bovine mastitis.

However, the rising threat of antibiotic resistance and a lack of awareness about the disease are expected to slow the market's growth over the forecast period.

Bovine Mastitis Industry Overview

The bovine mastitis market is moderately competitive and consists of several major players. In terms of market share, a few of the major players are currently dominating the market, including Zoetis, Merck & Co. Inc, Boehringer Ingelheim, Bayer AG, Elanco, Ceva, and West Way Health.

Bovine Mastitis Market Leaders

  1. Zoetis Inc.

  2. Merck & Co., Inc.

  3. Boehringer Ingelheim International GmbH

  4. Ceva

  5. West Way Health

  6. *Disclaimer: Major Players sorted in no particular order
Bovine Mastitis Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Bovine Mastitis Market News

  • In October 2022, NovaQuest Capital Management invested over USD 20 million in Mileutis Ltd, an Israeli biopharmaceuticals company, to help mitigate the use of antibiotics in animals. Mileutics is in the advanced stages of developing a product that treats and prevents bovine mastitis.
  • In August 2022, PortaCheck launched a PortaReader, a handheld device that detects subclinical mastitis cow-side in bovine milk. The PortaReader detects subclinical mastitis in fresh bovine milk samples right on the farm.

Bovine Mastitis Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Incidence of the Disease
    • 4.2.2 Increasing Product Launches for Animal Healthcare
    • 4.2.3 Technological Advancements in the Field of Drug Discovery and Development
  • 4.3 Market Restraints
    • 4.3.1 Rising Threat of Antibiotic Resistance
    • 4.3.2 Lack of Awareness About the Disease
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Type
    • 5.1.1 Clinical Mastitis
    • 5.1.2 Sub-clinical Mastitis
  • 5.2 By Product
    • 5.2.1 Antibiotics
    • 5.2.2 Surgery
    • 5.2.3 Vaccines
    • 5.2.4 Pain Killers
    • 5.2.5 Other Products
  • 5.3 By Route of Administration
    • 5.3.1 Intra-mammary
    • 5.3.2 Systemic
  • 5.4 By Therapy
    • 5.4.1 Lactating Period
    • 5.4.2 Dry Period
  • 5.5 By End User
    • 5.5.1 Hospitals and Clinics
    • 5.5.2 Veterinary Centers
    • 5.5.3 Other End Users
  • 5.6 By Geography
    • 5.6.1 North America
    • 5.6.1.1 United States
    • 5.6.1.2 Canada
    • 5.6.1.3 Mexico
    • 5.6.2 Europe
    • 5.6.2.1 Germany
    • 5.6.2.2 United Kingdom
    • 5.6.2.3 France
    • 5.6.2.4 Italy
    • 5.6.2.5 Spain
    • 5.6.2.6 Rest of Europe
    • 5.6.3 Asia-Pacific
    • 5.6.3.1 China
    • 5.6.3.2 Japan
    • 5.6.3.3 India
    • 5.6.3.4 Australia
    • 5.6.3.5 South Korea
    • 5.6.3.6 Rest of Asia-Pacific
    • 5.6.4 Middle East and Africa
    • 5.6.4.1 GCC
    • 5.6.4.2 South Africa
    • 5.6.4.3 Rest of Middle East and Africa
    • 5.6.5 South America
    • 5.6.5.1 Brazil
    • 5.6.5.2 Argentina
    • 5.6.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Zoetis Inc.
    • 6.1.2 Merck & Co. Inc.
    • 6.1.3 Boehringer Ingelheim International GmbH
    • 6.1.4 Elanco (Bayer AG)
    • 6.1.5 Ceva
    • 6.1.6 West Way Health
    • 6.1.7 Norbrook
    • 6.1.8 DeLaval
    • 6.1.9 ImmuCell Corporation
    • 6.1.10 Advanced Animal Diagnostics
    • 6.1.11 Nimrod Veterinary Products Ltd
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Bovine Mastitis Industry Segmentation

As per the scope of the report, bovine mastitis is an inflammatory disease of the udder tissue in the mammary gland caused due to physical trauma or microorganism infections. It is considered the most common disease leading to economic loss in dairy industries due to reduced yield and poor quality of milk. 

The bovine mastitis market is projected to register a CAGR of 5.1% during the forecast period. the bovine mastitis market is segmented by type (clinical and sub-clinical), product (antibiotics, surgery, vaccines, pain killers, and other products), route of administration (intra-mammary and systemic), therapy (lactating period and dry period), end user (hospitals, veterinary centers, and other end users), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments. The market report also covers the estimated market sizes and trends for 17 countries across major regions globally.

By Type Clinical Mastitis
Sub-clinical Mastitis
By Product Antibiotics
Surgery
Vaccines
Pain Killers
Other Products
By Route of Administration Intra-mammary
Systemic
By Therapy Lactating Period
Dry Period
By End User Hospitals and Clinics
Veterinary Centers
Other End Users
By Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Bovine Mastitis Market Research FAQs

How big is the Bovine Mastitis Market?

The Bovine Mastitis Market size is expected to reach USD 1.68 billion in 2025 and grow at a CAGR of 4.88% to reach USD 2.13 billion by 2030.

What is the current Bovine Mastitis Market size?

In 2025, the Bovine Mastitis Market size is expected to reach USD 1.68 billion.

Who are the key players in Bovine Mastitis Market?

Zoetis Inc., Merck & Co., Inc., Boehringer Ingelheim International GmbH, Ceva and West Way Health are the major companies operating in the Bovine Mastitis Market.

Which is the fastest growing region in Bovine Mastitis Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Bovine Mastitis Market?

In 2025, the North America accounts for the largest market share in Bovine Mastitis Market.

What years does this Bovine Mastitis Market cover, and what was the market size in 2024?

In 2024, the Bovine Mastitis Market size was estimated at USD 1.60 billion. The report covers the Bovine Mastitis Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Bovine Mastitis Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Bovine Mastitis Industry Report

Statistics for the 2025 Bovine Mastitis market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Bovine Mastitis analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.

Bovine Mastitis Market Report Snapshots